Ongoing Clinical Trials in Ph+ CML | CML Alliance
For Healthcare Professionals Outside the US
Send To a FriendPrint This PageChange Text Size

Ongoing Clinical Trials in CMLOngoing Clinical Trials in CML

Countries with ongoing clinical trials1


Please click on the image to enlarge it

As part of the Novartis Oncology commitment to improving the lives of patients with cancer, there are ongoing clinical trials in the following 5 categories:

  • Ph+ CML
  • Gastrointestinal stromal tumor (GIST)
  • Pharmacokinetics
  • Noninterventional studies
  • Other malignancies and diseases

These studies include both company-sponsored and investigator-initiated trials.


Please click on the image to enlarge it

For more information about trials that are still recruiting, please visit: clinicaltrials.gov


Next: Leading Scientific Discovery


Note: Before prescribing, please read full European Summary of Product Characteristics.

Reference

  1. Data on file. Novartis Pharma AG. Basel, Switzerland.